Dan Gallahan, Ph.D.

Portrait of Daniel Gallahan, the Deputy Director of the Division of Cancer Biology at the National Cancer Institute.

Cancer Systems Biology: Towards a Better Understanding of the Disease
Dan Gallahan, Ph.D.
Deputy Director, Division of Cancer Biology, National Cancer Institute, National Institutes of Health
Speaking Time:  8:30am-9:05am, 17-Feb-17 (Friday)
Speaking Location:  Ballrom-D

Cancer remains one of the most challenging and devastating diseases known to mankind.  Its negative impact on the quality of life and national economies constitute a world-wide health crisis, according to the World Health Organization (WHO).  While much progress has been made in our understanding of the disease along with corresponding breakthroughs in some specific treatments, further advances remain a major challenge to the scientific community. What we have learned is that cancer is a very diverse and multi-component disease involving not just one mutation or one cell but a finely orchestrated system of signaling networks and cellular niches interacting to enable the cancer to develop, metastasize, and survive. The speaker will outline the challenges of cancer research and recent activities within the scientific community and the National Cancer Institute (NCI) to address these challenges using a multi-disciplinary, systems biology approach.

Dan Gallahan is Deputy Director of the Division of Cancer Biology at the National Cancer Institute (NCI) and helps lead the Division in its mission of supporting and facilitating basic cancer biology research.  His primary focus at NCI is the application of integrated approaches, tools, and data sets to understanding cancer. He established and still oversees the Division’s efforts in cancer systems biology, the latest of which is the Cancer Systems Biology Consortium (CSBC).  As Deputy Director, he also assists in planning and implementing the NCI’s overall efforts in genomics, proteomics, computational biology, and nanotechnology, and is a liaison with other government and commercial entities in the areas of technology and systems biology. Dr. Gallahan is a molecular and cancer biologist with broad expertise in the fields of systems biology, breast cancer, technology development, and science policy. He was trained in Molecular Biology and Biochemistry at the University of Maryland, with additional post-doctoral training at the NIH and the German Cancer Research Center.  His post-doctoral work included training in cancer biology, proteomics, and bioinformatics. Prior to joining the Division of Cancer Biology, he had an active NCI intramural career in the Laboratory of Tumor Immunology and Biology.